Stay updated on Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial page.

Latest updates to the Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry v3.4.2 was added to the record history, and the government funding notice along with the v3.4.1 revision entry were removed.SummaryDifference0.8%

- Check21 days agoChange DetectedA government funding notice banner was added to the page. The revision history shows the version updated from v3.4.0 to v3.4.1.SummaryDifference0.8%

- Check28 days agoChange DetectedUI updates include a glossary toggle and color-coding explanations for changes, and the revision heading now shows v3.4.0 (replacing v3.3.4).SummaryDifference1%

- Check42 days agoChange DetectedA new revision entry v3.3.4 was added to the history, and the previous revision v3.3.3 was removed.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.3.3 was added to the Record History; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedThe Record History shows minor version updates: addition of Revision: v3.3.2 and deletion of Revision: v3.3.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial page.